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Antimicrobial peptides (AMPs) are good candidates to treat burn wounds, a major cause of morbidity,
impaired life quality and resources consumption in developed countries. We took advantage of a com-
mercially available hydrogel, Carbopol, a vehicle for topical administration that maintains a moist envi-
ronment within the wound site. We hypothesized that the incorporation of LLKKK18 conjugated to
dextrin would improve the healing process in rat burns. Whereas the hydrogel improves healing,
LLKKK18 released from the dextrin conjugates further accelerated wound closure, and simultaneously
improving the quality of healing. Indeed, the release of LLKKK18 reduced oxidative stress and inﬂamma-
tion (low neutrophil and macrophage inﬁltration and pro-inﬂammatory cytokines levels). Importantly, it
induced a faster resolution of the inﬂammatory stage through early M2 macrophage recruitment. In addi-
tion, LLKKK18 stimulated angiogenesis (increased VEGF and microvessel development in vivo). Moreover,
collagen staining evaluated by Masson’s Trichrome was visually much more intense after treatment with
LLKKK18, suggesting higher collagen deposition.
Overall, we generated an effective, safe and inexpensive formulation that maintains a moist environ-
ment in the wound, easy to apply and remove, and with potential to prevent infection due to the presence
of an antimicrobial peptide. These ﬁndings propel us to further study this LLKKK18-containing formula-
tion, setting the foundations towards a potential therapeutic approach for burn wound treatment.
Statement of Signiﬁcance
This work presents a newly developed formulation that holds great potential as a therapeutic approach
for burn treatment. It is based on the sustained delivery of an antimicrobial peptide – LLKKK18 – from
conjugates with dextrin, after degradation of dextrin backbone upon exposure to wound a-amylases.
Conjugates were further embedded in Carbopol, a commercially available hydrogel, suitable for topical
administration and that provides a moist environment to the wound. Overall, we obtained an efﬁcient,
safe and non-expensive formulation that improves burn wound healing, maintains a moist environment
within the wound, is easy to apply-and-remove, and has potential to prevent infection due to the pres-
ence of an antimicrobial peptide. Importantly, this is the ﬁrst time the wound healing ability of LLKKK18
is demonstrated and that its main mechanisms of action are identiﬁed.
 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.1. Introduction
Burn wounds are a major cause of morbidity and reduced qual-
ity of life and, in developed countries, they take up substantialhealth resources [1]. According to the World Health Organization
burns affect more than 100 million people worldwide every year.
Indeed, each European Union member spends on average 2–4% of
the health budget in wound care and in the US alone $7.5 billion
are spent every year for burn wound treatment [2]. Thus, develop-
ing safe, efﬁcient, easy-to-use and inexpensive wound treatments
became imperative.
250 J.P. Silva et al. / Acta Biomaterialia 26 (2015) 249–262Hydrogels have been often studied for pharmaceutical and
biomedical applications such as wound dressings and drug deliv-
ery systems. They are composed of cross-linked hydrophilic poly-
mers with a very high intrinsic content of water, providing a
semi-occlusive moist environment to the wound area, absorbing
the exudates, reducing pain and healing time, and being painless
on both application and removal [3]. The maintenance of a moist
environment is particularly relevant as it promotes cell prolifera-
tion and collagen deposition [4]. Most important, among the differ-
ent types of dressings available, hydrogels have been described as
the most suitable for partial-thickness burn wounds [5].
Many therapeutic agents, including growth factors (e.g. EGF,
TGF-beta) [6] and hormones [7] have been successfully used in
wound treatment. However, their high production costs discourage
their application [8]. In particular, antimicrobial agents like silver
sulfadiazine, iodine or medical grade honey have been incorpo-
rated into dressings as a way of keeping the wounds safe from
infections. However, many studies have shown that treatment
with these agents alone is not sufﬁcient to achieve complete
wound healing and in some cases, toxicity problems can ensue [9].
In this sense, antimicrobial peptides (AMPs), which are com-
monly small, cationic and amphipathic peptides [10], arise as suit-
able candidates for wound therapeutics. LL37 is a peptide that
belongs to the cathelicidin family of AMPs and is overexpressed
in several different cell types. LL37, in addition to its antimicrobial
activity, has been reported to be involved in mast cells and leuko-
cytes chemotaxis, angiogenesis and in promoting wound healing
[11,12]. Indeed, LL37 is overexpressed in the epidermis and within
the wound itself after injury [10]. However, the molecular mecha-
nisms involved in LL37 improvement of healing are not clear.
Recently, a recombinant version of this peptide that was able to
maintain its antimicrobial activity was produced using a
cost-effective method [13]. This recombinant LL37 was shown to
accelerate the dexamethasone-induced impaired healing of exci-
sional wounds in C57BL/6 mice [14], further suggesting its poten-
tial use as an inexpensive therapeutic agent.
Analogs of LL37 have also been engineered to enhance its
antimicrobial properties and to decrease cytotoxicity and binding
to plasma protein [15,16]. One of them, LLKKK18, in which polar
uncharged residues glutamine and asparagine, and negatively
charged aspartic acid are substituted by positively charged lysine
residues, displays higher hydrophobicity and cationicity than
LL37. This results in higher antimicrobial and chemoattractant
activity, as previously described [15]. However, to date nothing is
known about the ability of LLKKK18 to improve wound healing.
Exogenous administration of these peptides is usually ham-
pered by drug toxicity, as well as limited stability and solubility
[17]. PEGylation has been used for a long time to enhance protein
stability and improve pharmacokinetics and partially solves the
problems with these peptides’ administration, but cutaneous aller-
gic reactions and the non-biodegradability of poly(ethyleneglycol)
(PEG) may hinder its use [18]. A promising alternative is peptide
conjugation with dextrin, using a succinoylation method previ-
ously described [19]. Dextrin is a FDA approved polysaccharide,
non-immunogenic, biocompatible and efﬁciently excreted due to
its low molecular weight [20]; some applications comprise the
food and beverages industry (e.g. Cargill Inc. – São Paulo, Brazil)
or paper and packaging industry (e.g. LD Davis Industries – PA,
USA); dextrin stabilizes the peptide, protects it from proteases
and constitutes itself a release system, as it degrades upon contact
with the amylases present in wound tissue, releasing the peptide
over time [21,22].
In the work presented here we incorporated the Dextrin-
LLKKK18 conjugates in a Carbopol hydrogel for topical adminis-
tration. Carbopol is made of carbomers that are cross-linked to
form a structure with good ﬂow properties and buffering capacity,high viscosity, good biocompatibility, bioadhesive properties, good
thermal stability and good patient acceptability [23]. Upon release
from the hydrogel, dextrin degrades through the wound amylases
action, releasing the peptide in a sustained manner. This makes it
optimal for dermatological purposes, including wound healing
[24]. To our knowledge, this is the ﬁrst time that the therapeutic
potential of LLKKK18 is evaluated.2. Materials and methods
2.1. Reagents
Carbopol 974 NF was a kind gift from Lubrizol Inc. (Ohio, USA).
Custom synthesis of LLKKK18 was obtained from Schafer-N
(Copenhagen, Denmark). Other reagents were obtained as follows:
Dextrin (Tackidex B 167) from Roquette (Lestrem, France); tri-
chrome stain kit from ScyTek Laboratories (Logan, UT); ketamine,
xylazine, buprenorphine, from Henry Schein (Melville, NY). All
other reagents, unless stated otherwise, were purchased from
Sigma Aldrich (Oakville, Canada).
2.2. Dextrin modiﬁcation
Dextrin was succinoylated using a modiﬁed version of a method
previously described by Hreczuk-Hirst et al. [25], based on the
introduction of a carboxyl group in the dextrin backbone via an ester
linkage, in a 4-dimethylaminopyridine (DMAP)-catalyzed reaction.
Brieﬂy, 1 g (6.17  103 mol) of dextrin (Tackidex) with a
Mw  2000 Da was dissolved in 10 ml of anhydrous dimethylfor-
mamide (DMF). Dextrin succinoylation was achieved by subse-
quent addition of succinic anhydride (3.70  103 mol) and
DMAP (2.34  104 mol). The ﬂask with the reagents was purged
with nitrogen, sealed and left stirring at 50 C for 48 h. The reaction
mixture was then poured into 250 ml diethyl ether and left stirring
vigorously overnight, at room temperature. The ether was removed
by vacuum ﬁltration and the solid residues dissolved in 10 ml of
distilled water. The solution was dialyzed against 2 L of distilled
water for 6 h, with water being replaced every 2 h, in a dialysis
membrane with a molecular weight cut-off of 1000 g/mol. The dia-
lyzed solution was freeze-dried and kept at room temperature
until use. A ﬁnal yield of about 90–95% was obtained. The ratio
of reagents used was optimized to yield a modiﬁed dextrin that:
(1) would have enough functional groups to bind LLKKK18, and
(2) would be able to delay degradation by amylases in order to pro-
vide a sustained release of the peptide. The % mol succinoylation,
that is, the number of glucose monomers activated by succinic
anhydride per 100 monomers, was determined by titration of the
succinoylated dextrin with NaOH. Due to the tendency of NaOH
to absorb CO2 from the atmosphere, NaOH pellets were ﬁrst dried
and titrated with phthalic anhydride, prior to its use to titrate suc-
cinoylated dextrin. A batch with 8.8% mol succinoylation was
obtained and used for all the subsequent experiments.
2.3. Production of the Dextrin-LLKKK18 conjugates
LLKKK18 was conjugated with dextrin, using a modiﬁed version
of a method previously described [25], based on the binding of the
peptide free amines to the free carboxyl groups in the succinoylated
dextrin (DexSuc) backbone, which results in the formation of an
amide. Brieﬂy, 50 mg (2.92  104 mol DexSuc, corresponding to
2.6  105 mol COOH) of succinoylated dextrin were ﬁrstly
dissolved in 1 ml dH2O. 1-Ethyl-3-(3-dimethylaminopropyl)
carbodiimide (2.6  105 mol) and N-hydroxysuccinimide
(2.6  105 mol) were then added to the mixture and left stirring
for 30 min. LLKKK18 (5.15  107 mol), dissolved in 1 ml of dH2O,
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raised to8.0 by the dropwise addition of NaOH. The reaction mix-
ture was left stirring overnight (16 h). Conjugates were separated
from unbound peptide by passage over a desalting HiPrep 26/10
column (GE Healthcare, UK), using distilled water as the eluent.
The product was freeze-dried and kept at80 C until use. The pres-
ence of the conjugates (Mw  4,300 Da)was detected by quantifying
the amount of reducing sugars present in collected fractions through
the DNS assay (after treating the fractions with a-amylase) and by
determining the amount of peptide by the Waddell’s method [26].
Finally, dextrin-LLKKK18 conjugates were incorporated into a
Carbopol 974 NF (Lubrizol, Ohio, USA) hydrogel. A 0.5% Carbopol
solution was prepared in distilled water, at 50 C for 1 h, with stir-
ring. The desired amount of conjugate was added to the solution
until complete dissolution and the mixture was neutralized by the
dropwise addition of NaOH until it reached a pH of 6–6.5.
2.4. Burn wound model
All animal protocols were approved by the Institutional Animal
Care and Use Committee (IACUC) of the University of California
Riverside (UCR). Female adult Sprague–Dawley rats, weighing
around 200–240 g and obtained from the UCR vivarium, were
housed under a 12 h dark/light cycle in a room with controlled
temperature and humidity. Standard rat chow and water were sup-
plied ad libitum. Prior to the experiments, rats were anesthetized
with an intraperitoneal dose of 80 mg/kg ketamine and 16 mg/kg
xylazine. A partial thickness burn wound was made on the shaved
dorsum of the anesthetized rats with a 1.5 cm diameter brass
cylinder heated in a water bath at 80 C for 2 min and pressed
against the rat skin for 6 s. This method was based on the protocol
by Liu and colleagues [27]. Buprenorphine (0.05–0.1 mg/kg) was
administered immediately after the burn to ease post-burn pain.
At least 6 rats were used per group. About 250 ll of the
Carbopol hydrogel, alone or incorporating either succinoylated
dextrin or dextrin-LLKKK18 conjugates containing 15 lg of
LLKKK18, were topically applied every 3 days during the ﬁrst
9 days post-burn. Phosphate Buffered Saline (PBS) topically admin-
istered using the same regimen was used to evaluate the recovery
of the rat burn per se. A Tegaderm patch (3M, London, Canada) was
applied on top of the wounds to keep the hydrogel in place over the
burn. Wound tissues were collected 1 h after the burn was made
and at 3, 6, 9, 12, 15 and 18 days for tissue analysis. Normal skin
was also collected from an area distant from the burn for compar-
ison. Photographs of the wounds were taken at the same deﬁned
time points using a digital camera placed at a distance of 4 cm.
Wound size was then determined with the aid of ImageJ 1.46 soft-
ware (NIH, Bethesda, MD) until re-epithelialization was achieved.
2.5. Determination of oxidative stress levels
Oxidative stress in the burn wounds was determined by mea-
suring the activity of antioxidant enzymes in the tissue extracts.
40–50 mg of collected burn tissue were homogenized in a bullet
blender, for 5 min at 4 C, in the presence of zirconium oxide beads,
and 10 ll RIPA buffer (1% NP-40, 0.1% SDS, 50 mM Tris–HCl pH 7.4,
150 mM NaCl, 0.5% sodium deoxycholate, 1 mM EDTA) per mg of
tissue. Extracts were then centrifuged at 12,000 rpm for 15 min,
at 4 C. The supernatants were either immediately used or
aliquoted and stored at 80 C for later use.
Determination of superoxide dismutase (SOD) activity was
assessed using a commercially available kit (Cayman Chemical,
Ann Arbor, USA), following the manufacturer’s instructions. One
unit of SOD was deﬁned as the amount of enzyme required to
induce 50% dismutation of the superoxide radical and results were
expressed as U/ml of tissue extract.Hydrogen peroxide (H2O2) levelswere indirectly determined with
a commercial kit (Cell Technology Inc., Mountain View, USA). This
assay measures the amount of the ﬂuorescent product resoruﬁn
formed upon H2O2-induced oxidation of the non-ﬂuorescent sub-
strate 10-acetyl-3,7-dihydroxyphenoxazine in a reaction catalyzed
by peroxidase. Fluorescence was read at 530 nm (excita-
tion)/590 nm (emission) in a Victor 2 microplate reader. The
amount of H2O2 in the supernatants, which is proportional to the
resoruﬁn formed, was calculated from a H2O2 standard curve.
Catalase activity was measured by using a commercially avail-
able kit (Cayman Chemical, Ann Arbor, USA), according to the man-
ufacturer’s procedure. This assay makes use of the peroxidatic
capability of catalase. This enzyme reacts with methanol to pro-
duce formaldehyde in the presence of an optimal concentration
of H2O2. This formaldehyde was quantiﬁed spectrophotometrically
at 540 nm using 4-amino-3-hydrazino-5-mercapto-1,2,4-triazole
(purpald) as the chromogen. Upon oxidation, purpald-aldehyde
complexes change from colorless to a purple color. Catalase
activity was expressed as nmol/min/ml.
Glutathione peroxidase (GPx) activitywas measured indirectly by
a coupled reaction with glutathione reductase (GR), using a com-
mercially available kit (Cayman Chemical, Ann Arbor, USA). GPx
reduces H2O2 to H2O, while producing oxidized glutathione
(GSSG) in the process. GSSG is then recycled back to its reduced
state by GR and NADPH. Oxidation of NADPH to NADP+ is accompa-
nied by a decrease in absorbance at 340 nm. Under rate-limiting
conditions of GPx activity, the rate of decrease in the A340 is directly
proportional to the GPx activity in the sample. This rate was mea-
sured at 1 min intervals during 5 min in a Victor 2 microplate
reader and GPx activity was expressed as nmol/min/ml of tissue
extract.
2.6. Oxidative DNA damage
To measure the amount of oxidative DNA damage, 5–6 mg of
burn tissue were collected and homogenized in RIPA buffer, as
described above. DNA was extracted using the DNeasy Blood and
Tissue kit (Qiagen, Chatsworth, CA) according to the manufac-
turer’s instructions. DNA concentration was measured and purity
conﬁrmed by calculating the OD260/OD280 absorption ratio. 8-hyd
roxy-20-deoxyguanosine (8-OH-dG) levels, which correlate with
the amount of oxidative DNA damage, were measured spectropho-
tometrically at 405 nm using a DNA/RNA Oxidative Damage EIA kit
(Cayman Chemical, Ann Arbor, USA), following the manufacturer’s
protocol.
2.7. Lipid peroxidation assay
The Thiobarbituric Acid Reactive Substances (TBARS) assay,
which directly measures the amount of malondialdehyde (MDA)
and 4-hydroxynonenal (4-HNE), was used to quantify the levels
of lipid peroxidation in the tissues, using a commercially available
kit (Cell Biolabs Inc., San Diego, USA). Samples were reacted with
TBA at 95 C for 1 h and the MDA content detected ﬂuorometrically
at 540 nm excitation/590 nm emission. TBARS levels were then
calculated from a predetermined MDA standard curve.
2.8. Protein nitration
Nitrotyrosine levels, indicative of oxidative damage to proteins,
were measured with an ELISA kit (Cell Biolabs Inc., San Diego, USA).
Tissue samples were incubated in an ELISA plate with an
anti-nitrotyrosine primary antibody, followed by a horseradish
peroxidase (HRP)-conjugated secondary antibody. Nitrotyrosine
content was then measured spectrophotometrically at 412 nm
against a nitrated BSA standard curve.
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Histological analysis was performed on wound tissues collected
at speciﬁc time points after the burn was created. These tissues
were excised in a way to include an area of about 5 mm around
the wound edge and were immediately ﬁxed in 4% paraformalde-
hyde overnight in the cold room on rocker. Subsequently, theywere
incubated for 1 h with 0.1 M glycine, followed by sequential incu-
bations with 15% and 30% sucrose, for 6 h and overnight, respec-
tively. Tissues were then embedded in OCT (Tissue-Tek; Torrance,
USA), frozen in dry ice and stored at 80 C. Sections were stained
with Hematoxylin and Eosin. Connective tissue was analyzed by
staining wound sections with a modiﬁed Masson’s Trichrome stain
(ScyTek Laboratories, Logan, UT), according to the manufacturer’s
protocol. Brieﬂy, sections were ﬁxed with Bouin’s ﬂuid, followed
by staining with Weigert’s hematoxylin and by incubation with
Biebrich Scarlet/Acid Fuchsin. Differentiation was then performed
in a phosphomolybdic/phosphotungstic acid solution, followed by
incubation with Aniline Blue and acetic acid. Sections were dehy-
drated, mounted on a microscopy slide and visualized in a Nikon
Microphot-FXA microscope with a Nikon DS-Fi1 digital camera.
Collagen stained blue, keratin appeared red, cytoplasm stained pink
and cell nuclei were black.
2.10. Immunolabeling
Frozen sections on microscopy slides were ﬁxed in 4%
paraformaldehyde for 20 min, followed by an incubation with
0.1 M glycine for 20 min and blocking in 10% non-immune serum
of the secondary antibody species in PBS containing 0.1% Triton
X-100 for 30 min. Slideswere then incubatedwith the primary anti-
bodies in 1% BSA/PBS for 2 h at room temperature, as it follows:
1:200 FITC-labeled mouse anti-rat a-smooth muscle actin (a-SMA,
Sigma–Aldrich, St Louis, MO), 1:100 rabbit anti-rat F4/80 (Abcam,
Cambridge, MA) and 1:100 rabbit anti-rat myeloperoxidase (MPO,
eBioscience, San Diego, CA). Sections were then washed three times
with 0.1% BSA in PBS and in the case of MPO incubated with 1:25
FITC-labeled goat anti-rabbit secondary antibody (Life
Technologies, Grand Island, NY), for 1 h at room temperature. After
washing, slides were mounted in Vectashield containing DAPI
(Vector Laboratories, Inc. Berlingame, CA). Immunoﬂuorescence
was visualized and imaged using a Nikon Microphot-FXA ﬂuores-
cence microscope with a Nikon DS-Fi1 digital camera and
NIS-Elements software (Nikon Instruments Inc., Melville, NY).
2.11. Cytokines expression
Burn wound tissues were homogenized in RIPA buffer at 4 C for
5–10 min, as described above. Total protein in the tissues was
determined using the DC protein assay kit (Bio-Rad, Hercules,
CA) and a ProcartaPlex™ Multiplex Immunoassay was performed
according to the manufacturers’ protocol (eBioscience, Carlsbad,
CA). Levels of monocyte chemoattractant protein-1 (MCP-1),
Gro-alpha (Gro-a), vascular endothelial growth factor (VEGF) and
IL-10 were quantiﬁed using a Luminex™ 200 instrument
(Millipore, Billerica, MA) by monitoring the ﬂuorescence associated
with the different bead sets. Total rat TGF-b expression was deter-
mined using an immunosorbent enzyme-linked assay (ELISA) kit,
according to the manufacturer’s instructions (eBioscience,
Carlsbad, CA).
2.12. Statistical analysis
Statistical analysis was performed using GraphPad Prism 5
(GraphPad Software, La Jolla, CA). A Kolmogorov–Smirnov test
was performed to ascertain the normality of the distributed data.For neutrophil quantiﬁcation and angiogenesis-related assays, a
one-way ANOVA, followed by a Newman–Keuls comparison
post-test was conducted. Statistical analysis of wound closure
was performed with a two-way ANOVA, followed by a Bonferroni
comparison post-test. For antioxidant enzymes activities and cyto-
kine expression, a Kruskal–Wallis test, followed by Dunn’s
Multiple Comparison post-test was used. A 95% conﬁdence interval
was considered as statistical signiﬁcant.3. Results
3.1. Mechanisms of dextrin-LLKKK18 conjugate production
Dextrin-LLKKK18 conjugates were obtained after conjugation of
a free amine in the peptidewith a carboxyl group created in the dex-
trin backbone through succinoylation (Fig. 1A). FT-IR spectra con-
ﬁrmed the successful succinoylation of dextrin (Fig. SI-1A). Indeed,
succinoylated dextrin spectrum showed a transmittance peak
around 1730 cm1, which was absent in the unmodiﬁed dextrin
and that is typical for the ester groups inserted in the dextrin back-
bone [22]. Characteristic peaks of dextrin were also present in both
conditions at about 3390 cm1 (OH) and 2927 cm1 (CH, CH2).
A modiﬁed dextrin with 8.8% mol succinoylation was used to
conjugate LLKKK18 and the reaction resulted in the binding of
50% of the initial peptide added. In vitro degradation of succinoy-
lated dextrin and its peptide conjugates occurred at a much slower
pace than that of the non-activated dextrin (Fig. SI-1B). This is
important for a slow, sustained release of LLKKK18 upon contact
with amylases in the wounds. Peptide conjugation did not further
hinder the degradation of the functionalized dextrin. Also, the
release of the conjugates from the hydrogel was performed in a
system simulating the wound surface environment, using a
Transwell chamber. As depicted in Fig. SI-1C the peptide present
in the Carbopol hydrogel underwent an initial burst release up
to 35% during the ﬁrst 2 days but then declined to a slower
release up to day 35.
Since peptide conjugation may result in the loss of its activity,
we have also evaluated the antimicrobial activity of LLKKK18. As
shown in Fig. SI-2, LLKKK18 inhibited the growth of Escherichia coli
strain K12 in a dose-dependent manner, with a concentration of
0.35 ± 0.01 lM leading to a growth reduction of 50%. The conjuga-
tion with dextrin masked this antimicrobial activity, as the pep-
tide’s IC50 was calculated to be 1.77 ± 0.25 lM. However, the
incubation of the conjugates for 1 h with amylase prior to the assay
reinstated the antimicrobial activity of LLKKK18, which showed an
IC50 of 0.48 ± 0.03 lM.3.2. Burn wound improvement by treatment with LLKKK18
General morphology of the wounds treated with
conjugate-containing or blank hydrogels was evaluated over time
in the rat burn model shown in Fig. 2. Brieﬂy, we shaved the hair
from the rats’ dorso (Fig. 2A) and created 1.5 cm diameter partial
thickness burn wounds by pressing a brass cylinder heated at
80 C against the rats shaved skin (Fig. 2B and C). We then applied
the conjugate-loaded or blank hydrogels on top of the wounds
every 3 days (Fig. 2D).
Macroscopic analysis of the wounds showed the healing pro-
gression after the treatments were administered (Fig. 3A). A faster
reduction in wound size was observed in the presence of LLKKK18,
particularly up to day 12. After 18 days full wound closure was
attained for treatments containing Carbopol. In accordance with
the qualitative analysis, quantitative evaluation of wound closure
showed that the peptide accelerated the wound healing process,
as a signiﬁcant decrease in wound area was observed at days 6
Fig. 1. Schematics of the formation of Dextrin-LLKKK18 conjugates. (A) Dextrin was modiﬁed by reacting it with succinic anhydride in the presence of DMAP and DMF, at
50 C for 48 h. (B) Succinoylated dextrin then reacts with EDC, forming an amine-reactive O-acylisourea intermediate, (C) which reacts with NHS to form an amine-reactive
NHS ester. (D) Finally, free amines within LLKKK18 bound to the modiﬁed dextrin through stable amide bonds.
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the PBS-treated wounds, took longer to fully close than the
hydrogel-treated ones. Also, it should be noted that the succinoy-
lated dextrin alone embedded in Carbopol did not inﬂuence
wound healing. This is in accordance with Hardwicke and col-
leagues [22], who have previously demonstrated the healing
inability of succinoylated dextrin alone in a chronic wound model.
Therefore, the difference in the speed of wound recovery may only
be attributed to the peptide. By day 18 no signiﬁcant differences in
wound size were observed between treated and non-treated
wounds.
In general, re-epithelialization with a well-deﬁned epidermis
occurred with Carbopol alone and conjugate-containing treat-
ments, as shown in the cross-sections from the wound tissues at
day 18 post-burn (Fig. 4A). Indeed, higher magniﬁcation of the sec-
tions further conﬁrmed the good organization of these structures
(Fig. 4B). Moreover, when compared to control wounds,
LLKKK18-treated wounds showed a higher content of collagen well
organized in ﬁbrils as shown by the higher amount of the blue
color due to the Masson’s Trichrome staining (Fig. 4A and B).
Overall, these results indicated that this hydrogel system, and
in particular LLKKK18, is able to accelerate the burn healing
process, as well as to improve the quality of the newly formed
tissue.3.3. Regulation of the redox state in the burn wounds by LLKKK18
High intracellular levels of reactive oxygen species (ROS), which
occur during the initial stages post-burn, have been often
described in the literature as inducers of oxidative damage.
Nonetheless, their deleterious effects depend on their balance with
the natural antioxidants of the cells and, at lower levels, ROS can
actually function as second messengers, playing an important role
in the activation of signaling pathways responsible for stimulation
of wound healing [28].
Superoxide dismutase (SOD) acts as the ﬁrst line of defense
against superoxide anions (O2), by dismutating these anions to
hydrogen peroxide [29]. Indeed, SOD activity increased right after
the burn is made (Fig. 5A). However, this activity then decreased
signiﬁcantly during the ﬁrst 24 h in the LLKKK18-treated wounds
when compared with carbopol-treated wounds. Although SOD
activity was maintained at normal skin levels in both conditions
between days 3 and 6, a signiﬁcant increase was observed in the
LLKKK18-treated wounds by day 9.
Also immediately after the burn, hydrogen peroxide concentra-
tion was increased. Both treatments induced a decrease in H2O2
levels after 24 h (Fig. 5B). Whereas in the Carbopol-treated
wounds H2O2 concentration then stabilized at normal skin values,
in the presence of LLKKK18 H2O2 was decreased to lower levels
Fig. 2. Partial-thickness rat burn wound model. (A) Hair from Sprague–Dawley rats’
dorsum was removed and (B) a brass cylinder heated at 80 C was used to create (C)
identical burns on the backs of the rats. (D) About 250 ll of a Carbopol hydrogel on
a spatula ready to be applied on top of the burned tissue.
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concentration of H2O2 rose again to signiﬁcantly high levels at
9 days post-burn paralleling the increase in SOD levels.There are two antioxidant enzymes, catalase and glutathione
peroxidase (GPx), which come into play to remove the excess of
H2O2. A decrease in the activity of GPx was observed for both
LLKKK18-treated and non-treated conditions after 24 h.
Carbopol treatment then resulted in the stabilization of catalase
activity at normal skin levels up to day 9 post-burn. Similar levels
were observed after LLKKK18 treatment but only up to day 6. After
this time the peptide induced an increase in catalase when com-
pared to Carbopol-treated control reaching a threefold increase
at day 9 (Fig. 5C). GPx activity decreased signiﬁcantly compared
with the Carbopol-treated control for the ﬁrst 24 h but then
started to increase to reach the levels of the control wounds at
3 days post-burn and stabilized at high levels between days 6
and 9 (Fig. 5D).
ROS are highly reactive and can cause damage to biologically
relevant macromolecules like DNA, lipids and proteins [30]. DNA
damage was evaluated by the measurement of 8-OH-dG levels in
the tissues. Despite a slight increase in oxidative DNA damage
1 h after the burn (p < 0.05), no signiﬁcant differences were
observed between LLKKK18-treated and Carbopol-treated
wounds up to 9 days post-burn. Lipid peroxidation, as indicated
by MDA levels in the tissue, did not undergo any signiﬁcant differ-
ences in the Carbopol-treated wounds until day 6, rising only by
day 9 post burn (Fig. 5E). A similar trend was observed when
wounds were treated with LLKKK18, although MDA concentration
in this case was signiﬁcantly lower than the control throughout the
nine days of the study. Interestingly, during the ﬁrst 6 days under-
going peptide treatment lipid peroxidation levels were practically
negligible (Fig. 5F). Regarding protein nitration, indicated by
nitrotyrosine concentration in the tissues, no initial differences
were observed between burn and normal skin (Fig. 5G). Also, no
variations were observed in the control wounds up to day 6.
Nevertheless, at this time protein nitration levels were signiﬁ-
cantly lower in the LLKKK18-treated wounds. Similarly to what
occurred for lipid peroxidation, an increase in nitrotyrosine levels
was detected at day 9. However, no statistically signiﬁcant differ-
ences were observed between the Carbopol-treated and
peptide-treated wounds (Fig. 5G).
These results indicate that LLKKK18 reduced the initial levels of
oxidative stress to some extent, potentially preventing ROS damag-
ing effects during the ﬁrst days post-burn.3.4. LLKKK18 stimulates the development of new blood vessels
Development of new blood vessels during the healing of the
burned tissue was assessed by immunolabeling the tissue sections
for a-smooth muscle actin (a-SMA), a protein present in the
smooth muscle cells surrounding the microvessels [31]. The angio-
genic process in response to injury is important to promote a more
effective transport of nutrients and cytokines to the wound site.
Treatment with LLKKK18 resulted in approximately 3-fold increase
in the number of new blood vessels that developed in the tissue
(Fig. 6A and B). However, no differences were observed between
treatments in blood vessel width or area (Fig. 6C and D). To conﬁrm
that this peptide is angiogenic we performed injections with
LLKKK18 under the skin of C57Bl/6 mice during 4 consecutive days.
Mouse tissues collected from the injection sites displayed a signif-
icantly larger blood vessel network (about 1.5-fold, p < 0.01), com-
pared to PBS alone (Fig. SI-3A and B). VE-cadherin, also known as
CD144, is localized at the adherens junctions that old the endothe-
lial cells together. Immunoblot analysis for this molecule showed a
1.85-fold increase in VE-cadherin levels in LLKKK18 treated tissues
(p < 0.01, compared to control), indicating that the microvessels
were tighter and potentially more stable in the presence of the
peptide (Fig. SI-3C).
Fig. 3. Treatment of rat burn wounds with LLKKK18. (A) Macroscopic changes in wound size over time after treatment with the peptide in comparison with the hydrogel
alone. (B) Percentage of wound closure over time after wound tracing and ImageJ analysis. Arrows indicate the days at which treatments were administered. Data in the graph
represent the mean ± S.D. for an n = 6. **p < 0.01, compared to carbopol.
J.P. Silva et al. / Acta Biomaterialia 26 (2015) 249–262 2553.5. Inﬂammation regulatory role of LLKKK18
After burn injury, inﬂammatory cells are recruited to the wound
site, initiating the inﬂammatory stage of the healing process, which
is characterized by the sequential inﬁltration of neutrophils and
macrophages [32]. The presence of these cells in the burn wound
tissue was evaluated after treatment with LLKKK18.
Neutrophils play a protective antimicrobial role, eliminating
invading microbes, as well as damaged and denatured extracellu-
lar matrix components from the wound site [33]. However, pro-
teases and ROS released by these cells may also result in some
additional damage [32]. Neutrophils were identiﬁed with
MPO-staining, characteristic of granulocytes (Fig. 7A). The insert
in this ﬁgure shows the presence of the MPO-containing granules.
Treatment with LLKKK18 resulted in reduced neutrophil response
in day 1 comparing to carbopol-treated wounds (Fig. 7B). This
suggests that the peptide down-regulates the acute inﬂammatory
reaction.
Macrophages play several roles during the healing process.
Early after the wound is inﬂicted, they further promote the inﬂam-
matory response by releasing cytokines that recruit additional
leukocytes [32]. In addition, they are involved in the clearance of
apoptotic neutrophils from the wound a few days post-injury,beginning the decline of inﬂammation [34]. As macrophages clear
the tissue from these apoptotic cells they change their phenotype
to a reparative state, with subsequent release of molecules that
stimulate the migration of ﬁbroblasts, epithelial and vascular
endothelial cells into the wound, setting the stage for tissue
remodeling [32].
The presence of macrophages in the burn tissues was evaluated
by ﬂow cytometry. The rationale for differentiating macrophage
phenotype is shown in Fig. SI-4. Doublets were discriminated from
single cells by plotting FSC-H vs FSC-A. Then live cells were gated
and from that positive and negative gates were deﬁned to distin-
guish between M1 and M2 skewed macrophages. Patterns of
macrophage recruitment differed between Carbopol- and
LLKKK18-treated wounds (Fig. SI-5). Initially, a higher M1 macro-
phage recruitment occurred in Carbopol-treated wounds com-
pared to LLKKK18 (Fig. SI-5). Indeed, the lower M1 inﬂux after
peptide treatment correlated with the lower oxidative stress levels
and decreased damage observed. Moreover, an earlier M2 macro-
phage recruitment was observed in the LLKKK18-treated wounds
(day 6 vs day 12, for peptide and carbopol-treated, respectively),
as depicted in Fig. SI-5. This higher M2 macrophages inﬂux might
have also contributed to the lower inﬂammatory response
observed in the presence of the peptide.
Fig. 4. Histological evaluation of burn wound cross-sections. (A) Tissues from day 18 post-injury were stained using Hematoxylin and Eosin and Masson’s Trichrome. Higher
collagen content (blue) with well formed ﬁbrils is shown in the LLKKK18-treated tissues. (B) Higher magniﬁcation of tissue equivalent to those shown in (A). (For
interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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mation by the LLKKK18 released from the conjugates was further
studied by evaluating the levels of the chemokines Growth regu-
lated oncogene-alpha (Gro-a) and monocyte chemoattractant
protein-1 (MCP-1) because they are chemotactic for neutrophils
and monocytes, respectively (Fig. 8A). LLKKK18 signiﬁcantly
decreased Gro-a during the ﬁrst 3 days after wounding.
Thereafter, the levels of this chemokine were very similar to those
in Carbopol-treated controls. This is consistent with the neu-
trophil immunolabeling results, which showed much less staining
for neutrophils in the LLKKK18-treated wounds during the ﬁrst
3 days after injury (Fig. 7A and B).MCP-1, one of the chemokines involved in inﬁltration of mono-
cytes into the wound tissue that go on to differentiate into macro-
phages, was decreased on day 3 (Fig. 8B). Notably, at day 3 it was
signiﬁcantly lower in LLKKK18-treated wounds and remained at
these very low levels up to day 12.
Vascular endothelial growth factor (VEGF) is a signal protein
involved in several biological processes, from inﬂammation to
angiogenesis [35]. In our burn model VEGF concentration gradually
increased until it reached a peak by day 6, in both conditions. At
this time is when the microvessels in the burn tissue are develop-
ing at high levels. Moreover, between days 3 and 9, VEGF levels
were signiﬁcantly higher in the tissues treated with LLKKK18
Fig. 5. Regulation of initial redox state in burn wounds. LLKKK18 effects on oxidative stress occurring during the ﬁrst days post-injury was evaluated by analyzing the
activities of antioxidant enzymes and hydrogen peroxide levels. (A) Superoxide Dismutase (SOD) dismutates superoxide radical producing (B) H2O2 in process. This H2O2 is
then removed by the activities of (C) catalase and (D) glutathione peroxidase. Oxidative damage to (E) DNA, (F) lipids and (G) proteins was also evaluated. Data represent the
mean ± S.D. of at least three independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001, compared to carbopol. B = Burn skin.
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tern of high levels of VEGF in peptide-treated burn wound tissue
correlated well with its ability to increase angiogenesis (Fig. 6).
The concentration of interleukin-10 (IL-10), an
anti-inﬂammatory cytokine, was decreased in the burned skin 1 h
after the burn was made (Fig. 8D). It has been shown that IL-10
levels increase during the early stages of burn wound response, fol-
lowed by its return to baseline levels around day 7 [36]. We also
found that LLKKK18 signiﬁcantly increased the levels of IL-10 early
post wounding when compared with the Carbopol treatment that
caused the increase at day 6. These data support the beneﬁcial roleof the peptide on an early IL-10 response, which is known to help
resolve the inﬂammatory response post-injury [37].
Transforming growth factor-beta (TGF-b) is another cytokine
involved in different signaling mechanisms, including inﬂamma-
tion, cell proliferation, differentiation, scarring and tissue remodel-
ing [38]. The levels of this cytokine go up-and-down throughout the
wound healing process, with a similar proﬁle between peptide and
control-treated groups (Fig. 8E). Major differences were observed at
days 1 and 18. Indeed, at day 1, while TGF-b increased in the control
group to higher values than the ones observed 1 h post-burn,
LLKKK18-treated tissues showed signiﬁcant decrease with levels
Fig. 6. Stimulation of angiogenesis by LLKKK18. (A) Representative images of burn tissue sections stained with a-smooth muscle actin (aSMA) at day 9. (B) The number of
blood vessels per area was counted in at least 10 different ﬁelds. (C) Area and (D) width of the blood vessels were calculated using ImageJ. Bars show the mean ± S.D. *p < 0.05,
compared to carbopol.
Fig. 7. Recruitment of inﬂammatory cells by LLKKK18. (A) Burn wound sections from days 1 and 3 were immunolabeled for myeloperoxidase (MPO), a neutrophil marker. (B)
Quantiﬁcation of neutrophils present in either treatment, using ImageJ software. LLKKK18 reduced the early neutrophil recruitment observed in carbopol. Data represent the
mean ± S.D. of at least three independent experiments. **p < 0.01, compared to carbopol.
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concentration of TGF-b present in the tissues was signiﬁcantly ele-
vated in the tissues treated with the peptide (Fig. 8E).
4. Discussion
Burns represent a devastating form of trauma, involving severe
pain, distress and decrease of life quality for many patients world-
wide. Indeed, thermal injury can severely compromise the skin
barrier, affecting important functions such as body ﬂuid homeosta-
sis, thermoregulation and protection against infection [39,40].
Hydrogels were shown to induce faster healing of
partial-thickness burn wounds, since they maintain a moistenvironment, as well as contribute to wound debridement by rehy-
dration of non-viable tissue [5,41].
In this work we conjugated LLKKK18 with dextrin, protecting
the peptide from being readily degraded in the harsh burn tissue
environment, while allowing its sustained release over time,
because exposure of dextrin to the high concentration of wounds
a-amylases [42] results in its backbone degradation, with subse-
quent peptide release. A degree of dextrin modiﬁcation of 8.8%
mol was sufﬁcient to delay degradation of this molecule by
a-amylase. Moreover, the incorporation of the conjugates into
Carbopol hydrogels presented several advantages, as not only it
provided the required moist environment to the wound site, it also
performed as a carrier for the topical application of the conjugates.
Fig. 8. Chemokine and Cytokine levels after treatment of the burn wounds with LLKKK18. A multiplex assay was performed to measure the levels of different chemokines and
cytokines: (A) Gro-a, which is a cytokine that chemoattracts neutrophils; (B) monocyte chemoattractant protein (MCP-1), which recruits monocytes that then differentiate
into macrophages in the tissue; (C) vascular endothelial growth factor (VEGF), which stimulates the angiogenesis; (D) Interleukin-10 (IL-10), an anti-inﬂammatory cytokine;
and (E) Transforming growth factor-beta (TGF-b), which is involved in many different biological processes, including inﬂammation, angiogenesis, and extracellular matrix
production and deposition. TGF-b levels in the homogenates were determined using an ELISA assay. *p < 0.05, **p < 0.01, ***p < 0.001, compared to carbopol. B = Burn skin.
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time leading to sparser change of the dressing.
Antimicrobial properties against different strains, including
E. coli and Staphylococcus aureus have been previously attributed
to LLKKK18 [15,16]. Also, we have recently reported this peptide’s
ability to reduce Mycobacterium avium’s growth [43]. In this work,
we determined its antimicrobial activity against the E. coli strain
K12 and observed that when conjugated with dextrin, LLKKK18
has its activity decreased, in agreement with what has been previ-
ously reported for other molecules [22]. However, after degrada-
tion of the conjugates by amylase, which can also be found at
wound sites, the antimicrobial activity of LLKKK18 was restored.
Although the involvement of the human cathelicidin LL37 in
wound healing has already been described [14], its effects on the
wound healing processes, as well as the mechanisms of action of
the modiﬁed analogue LLKKK18 are still unknown. As we show
here, the peptide released from the conjugates, when compared
to the controls treated with hydrogel, helped accelerate the healing
process as well as contributing to proper collagen deposition, with
better ﬁber formation, in the granulation tissue.
Burns trigger a myriad of systemic responses, including an
increasedmetabolic rate, elevated energy expenditure, faster break-
down of proteins, lipids and polysaccharides, immunodeﬁciencyand delayed wound healing, which are mainly mediated by high
doses of ROS and activated neutrophils [44,45]. We showed that
LLKKK18 reduced this initial oxidative burden, as indicated by lower
levels of H2O2 and antioxidant enzymes (in particular SOD and GPx)
aswell as by a lowered recruitment of neutrophils to the burn tissue.
Indeed, Gro-a, a neutrophil chemoattractant cytokine, was present
at lower levels during the ﬁrst 3 days in LLKKK18-treated burns.
Also, immunostaining showed amuch lower number of neutrophils
in the LLKKK18-treated wounds in the ﬁrst day. As a result of
reduced oxidative stress, damage to major cellular biomolecules,
in particular lipids, was also decreased in the presence of LLKKK18,
compared to the hydrogel alone.
Moreover, the overall reduction of the initial oxidative stress in
the presence of the peptide is of major importance as it can help
achieve faster wound recovery and tissue repair. Indeed, it has been
reported that at concentrationsbelow those required to causeoxida-
tive damage, ROS may regulate intracellular signal transduction
pathways through redox-dependent mechanisms, including vascu-
lar smooth muscle cell growth and migration, modulation of
endothelial function and modiﬁcation of the extracellular matrix
[46].On theotherhand, the imbalancebetweenoxidantsandantiox-
idants in favorof the formerhasbeen reportedasone factor resulting
in the entrapment of wounds in the inﬂammatory stage [33].
260 J.P. Silva et al. / Acta Biomaterialia 26 (2015) 249–262An unexpected increase in oxidative stress was observed at day
9, following a signiﬁcant increase in SOD and H2O2 levels.
However, no signiﬁcant damage was induced to DNA, lipids or pro-
teins, which may be related to the increase in catalase activity,
counteracting H2O2 production by converting it into water.
Regarding GPx activity, a similar trend was observed between
LLKKK18- and hydrogel-treated wounds over time, suggesting lit-
tle or no inﬂuence of the peptide on this antioxidant enzyme’s
activity.
Oxidation reactions have for a long time been implicated in col-
lagen crosslinking in the presence of high glucose concentration
[47]. A study conducted by Elgawish and colleagues [48] provided
evidence for a key role played by H2O2 in collagen cross-linking
and thermal stability in vivo. The authors followed tissue glycation
kinetics in tendons implanted in diabetic rats and concluded that
faster glycoxidation and crosslinking occurred 30 days after dia-
betes onset, i.e. by the time high tissue glycation was detected.
However, when catalase or other antioxidants were injected, colla-
gen crosslinking was suppressed. High energy expenditure
observed in burns has also been reported to increase glycogenoly-
sis with a subsequent enhanced glucose production that results in
a hyperglycemic state [49]. In this sense, it is reasonable to con-
sider that the LLKKK18-induced hydrogen peroxide formation in
burn wounds at day 9 may actually be accelerating collagen
crosslinking, thus contributing for a faster remodeling of the extra-
cellular matrix.
Angiogenesis, the formation of new blood vessels from
pre-existing ones, is a key factor for proper burn wound healing,
as the increased metabolic rate observed in such wounds demands
the rapid and efﬁcient transport of nutrients, inﬂammatory cells,
cytokines and chemokines to the wound site [50]. Although
pro-angiogenic properties have already been attributed to LL37
[14], no data had been reported on the ability of LLKKK18, a similar
but smaller peptide, to induce angiogenesis. This peptide is also
more cationic and hydrophobic than LL37, with clear implications
in attaining higher antimicrobial and chemoattractant activity than
its analogue [15]. Moreover, its smaller size is advantageous as not
only facilitates its transport across cell membranes but also costs
less to synthesize. Here we showed the clear pro-angiogenic effect
of LLKKK18 in vivo, as it induced a threefold increase in the density
of newly formed microvessels, compared to the hydrogel alone.
This property was further conﬁrmed in a mouse model. Similarly
to the ﬁndings in the rat model, a pronounced angiogenic effect
was observed in the presence of LLKKK18. Furthermore, because
sometimes the new vessels are leaky, thus hampering the trans-
port of substances to the wound site and increasing edema [38],
we quantiﬁed the levels of vascular endothelial cadherin
(VE-cadherin), a protein involved in the regulation of vascular per-
meability and vessel tightness [51]. The expression of VE-cadherin
was increased in the presence of LLKKK18, indicating that this pep-
tide improved the integrity and stability of the newly formed
microvessels.
An inﬂammatory response develops in the burn tissue during
the ﬁrst few days post-injury, initiating cell migration and prolifer-
ation, as well as clearance of cell debris [33]. Importantly, moisture
balance, as the one provided by the hydrogel, has been reported as
critical for healing, because the moist environment facilitates the
action of growth factors, cytokines and chemokines [4].
Nevertheless, successful repair of damaged tissue requires the res-
olution of the inﬂammatory response, as a prolonged inﬂammatory
phase has been described to result in postponed, incomplete or
uncoordinated healing process that may ultimately lead to a
chronic wound [32,52].
LLKKK18 released from the dextrin-conjugates stimulated a
lower inﬂammatory response than the Carbopol hydrogel alone
during the initial days post-injury. In addition to the decrease inGro-a and in neutrophil numbers, lower concentration of MCP-1
was detected. MCP-1 is a pro-inﬂammatory cytokine known to
recruit monocytes that differentiate into macrophages in the
wound site. Macrophages can easily adapt to different biological
functions due to their plasticity, switching phenotype according
to the surrounding signals. Broadly, and depending on the activa-
tion pathway, macrophages can be M1 type (classically-activated)
or M2 type (alternatively-activated) macrophages. M1 macro-
phages, which are induced by LPS or IFN-c, are characterized as
pro-inﬂammatory and elicit a type 1 response. On the other hand,
M2 macrophages elicit an anti-inﬂammatory response stimulated
by IL-4, IL-13 or IL-10 [53]. Our data show that treatment with
LLKKK18 results in early recruitment of M2 macrophages, suggest-
ing a faster resolution of the inﬂammatory stage and a potential
regulation of angiogenesis through M2 macrophage skewing.
Indeed, it has been shown that M2 macrophages have a higher
angiogenic potential compared to other subsets [54]. Consistent
with these ﬁndings, levels of IL-10, known to be released mainly
by M2 macrophages, were also increased in the presence of
LLKKK18 during the ﬁrst few days post-injury. IL-10 is an
anti-inﬂammatory cytokine whosemajor inﬂuence on the polariza-
tion of macrophages and their ability to regulate angiogenesis has
already been previously reported [55]. After an initial stage of heal-
ing in which the main concern is to avoid propagation of damage,
wound mediators and inﬂammatory cells start being recruited to
the wound site, preparing the tissue for proliferation and remodel-
ing. As a result, the wound starts to close and a reduction in wound
area may occur. In agreement with this, the early increase in IL-10
levels, accompanied by the earlier recruitment of M2macrophages,
observed in the peptide-treated wounds, coincides with a
signiﬁcant reduction of wound area at day 6. Moreover, it should
also be noted that a prolonged inﬂammatory stage might turn a
wound into chronic. Interestingly, we observed that while
anti-inﬂammatory cytokines and macrophages were earlier stimu-
lated, pro-inﬂammatory molecules like Gro-a and MCP-1 were
maintained at low levels after the ﬁrst days post-wound.
In addition, the concentration of VEGF rose almost at the same
time in the LLKKK18-treated wounds. VEGF has been described as
one of the most important stimulators of angiogenesis and vasop-
ermeability, and is produced by macrophages as a result of the
burn hypoxic environment to stimulate endothelial cells migration
and proliferation [35,56]. Indeed, this increase in VEGF levels coin-
cided with a faster decrease of the wound area (Fig. 3B), suggesting
the importance of angiogenesis stimulation by LLKKK18 to the
overall acceleration of wound healing, mainly observed at days 6
and 12.
The increase in M1 macrophages that occurred at day 9 in
LLKKK18-treated wounds may be related to the augmented H2O2
concentration. Indeed, it has been reported that H2O2 modulates
expression of leukocyte and endothelial adhesion molecules adhe-
sion [28]. Nevertheless, this H2O2 increase at day 9 may help
explain the stall in healing, as it may result in a temporary increase
in oxidative stress.
TGF-b participates in different cellular functions, including
inﬂammation, stimulation of angiogenesis, collagen synthesis and
tissue remodeling [38,57]. Its involvement in these processes
could, at least partially, explain the up-and-down regulation of this
cytokine, which we observed during wound healing progression.
Wang and colleagues [58] have reported the rapid up-regulation
of TGF-b after injury, suggesting it to be responsible for the initia-
tion of inﬂammation, together with other cytokines, such as
MCP-1, and formation of granulation tissue. Indeed, we noticed
an initial increase in TGF-b in the control wounds. However,
LLKKK18 kept this cytokine at normal skin levels, further conﬁrm-
ing the lowered inﬂammatory response elicited by this peptide.
Moreover, the enhanced TGF-b expression observed at 18 days post
J.P. Silva et al. / Acta Biomaterialia 26 (2015) 249–262 261burn raises some concern that while healing the wound faster,
LLKKK18 may have some scarring effects. However, it may also
be related to the role played by TGF-b in tissue remodeling.
Indeed, it has been known for some time that TGF-b released from
inﬂammatory cells stimulates ﬁbroblasts to contract the wound
matrix [59] and for stimulating collagen and ﬁbronectin produc-
tion, thus strengthening the wound tissue [58].
5. Conclusions
LLKKK18 released from dextrin conjugates incorporated in
Carbopol hydrogels accelerates the healing process and improves
the tissue quality of burn wounds. This was achieved through reg-
ulation of initial oxidative stress and inﬂammation. Also important,
it induces a faster resolution of the inﬂammatory phase by recruit-
ing M2 macrophages early post-injury. Moreover, it stimulates
angiogenesis in the granulation tissue, which is of utmost rele-
vance to attain the rapid transport of growth factors, cytokines
and chemokines to the wound site, thus contributing to a faster
wound healing with proper tissue organization.
In this sense, this work presents a new, safe, inexpensive and
effective formulation for the treatment of burn wounds, which is
easy to apply and remove, maintains a moist environment and
with the potential to keep the wound site free from infections
due to the presence of an antimicrobial peptide. Therefore, this
delivery system has great potential as a therapeutic approach for
burn wound treatment. Nevertheless, further experiments still
have to be performed before taking it to the clinic.
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